Coronavirus company news update

16 April 2020 (Last Updated April 16th, 2020 10:43)

16 April

Synapse Biomedical has received the Emergency Use Authorization (EUA) from US Food and Drug Administration (FDA) for its TransAeris DPS, which will aid in weaning patients off the ventilators. The system will be used for patients who are deemed to be high risk of weaning failure, as decided by the healthcare provider amid the Covid-19 pandemic. The TransAeris system conditions the diaphragm of the patient to reduce the occurrence of ventilator-induced diaphragm dysfunction. The system was awarded the CE Mark approval and is under clinical investigation in the US.

Read full story here.

Accelerate Diagnostics has entered into a commercial supply and collaboration agreement with BioCheck. Accelerate will distribute the BioCheck MS-FAST, which is an automated chemiluminescence immunoassay analyser, as well as the BioCheck's SARS-CoV-2 tests to detect IgG and IgM antibodies, in North America, Europe and the Middle East. The system and the tests can process blood, serum, or plasma samples to detect antibodies in 30 minutes, which will confirm the exposure and potential immunity to Covid-19.

Precision health platform 1Health.io has announced the immediate availability of 50,000 FDA-approved Covid-19 test kits for telehealth-supervised self-collection. 1Health.io and its lab partners have started preparations to provide 300,000 test kits by May in a bid to boost Covid-19 testing in the US. 1Health.io plans to provide the test kits to hospital systems and doctors to collect specimens remotely in the clinic from patients exhibiting Covid-19 symptoms.

IT consultancy Altoros has launched a Fever Screener to aid in preventing the spread of Covid-19 coronavirus. The system uses artificial intelligence (AI) to identify individuals who have a high body temperature, which is said to be a major symptom in infected people. The system can simultaneously screen up to 30 individuals at a 3m distance and provides an accuracy of ±0.3°С (±0.6°F). It is also capable of supporting repeated temperature monitoring to detect potentially infected individuals at definite time intervals.

Novant Health Michael Jordan Family Medical Clinic has announced that from 15 April, it will temporarily transform into a Covid-19 respiratory assessment centre along with two mobile health units to screen for Covid-19 in East and West Charlotte, North Carolina in the US. This move is expected to offer education, assessment and testing of Covid-19 in the high risk communities in Charlotte.